Company: CPSH
Filing Date: 2025-10-06
Form Type: 424B5
Source: 0001437749-25-030558
Chunk: 5

Company: CPS TECHNOLOGIES CORP/DE/
Filing Date: 2025-10-06
Form: 424B5
Chunk 5
---
 Interest                                          |     | One or more of our board members or executive officers may purchase (directly or through related entities) shares of common stock in this offering at the public offering price. Because indications of interest are not a binding agreement or commitment to purchase, these individuals may determine to purchase shares in this offering or the underwriter may determine to sell or not to sell shares to these individuals. |
| Risk Factors                                                     |     | Investing in our common stock involves a high degree of risk. See “Risk Factors” beginning on page [●] of this prospectus supplement and in the documents incorporated by reference into this prospectus supplement and the accompanying prospectus for a discussion of the factors you should carefully consider before deciding to invest in our common stock.                                                                 |
| Ticker symbols                                                   |     | “CPSH”                                                                                                                                                                                                                                                                                                                                                                                                                           |

The number of shares of common stock to be outstanding immediately after this offering is based on 14,529,277 shares outstanding as of October 3, 2025, which excludes

| • | 1,077,800 shares of common stock issuable upon exercise of outstanding options, |

| • | 421,400 shares of common stock reserved for future issuance of awards pursuant to the Company’s 2020 Equity Incentive Plan. |

Unless otherwise indicated, this prospectus assumes no exercise of outstanding stock options or warrants and no settlement of outstanding restricted stock units.

<div align='center'>S-3

RISK FACTORS</div>

You should consider carefully the risks described below and discussed under the section captioned“Risk Factors”contained in our Annual Report on Form 10-K for the year ended December 28, 2024, and as updated by our subsequent filings under the Securities Exchange Act of 1934, as amended, or the Exchange Act, including our Quarterly Reports on Form 10-Q for the periods ended March 29, 2025 and June 28, 2025, which are incorporated by reference in this prospectus supplement and the accompanying prospectus in their entirety, together with other information in this prospectus supplement, the accompanying prospectus and the information and documents incorporated by reference in this prospectus supplement and the accompanying prospectus, and any free writing prospectus that we have authorized for use in connection with this offering before you make a decision to invest in our common stock. If any of the following events actually occur, our business, operating results, prospects or financial condition could be materially and adversely affected. This could cause the trading price